204 related articles for article (PubMed ID: 26559973)
1. Molecular Basis of mRNA Cap Recognition by Influenza B Polymerase PB2 Subunit.
Xie L; Wartchow C; Shia S; Uehara K; Steffek M; Warne R; Sutton J; Muiru GT; Leonard VH; Bussiere DE; Ma X
J Biol Chem; 2016 Jan; 291(1):363-70. PubMed ID: 26559973
[TBL] [Abstract][Full Text] [Related]
2. Recognition of cap structure by influenza B virus RNA polymerase is less dependent on the methyl residue than recognition by influenza A virus polymerase.
Wakai C; Iwama M; Mizumoto K; Nagata K
J Virol; 2011 Aug; 85(15):7504-12. PubMed ID: 21593178
[TBL] [Abstract][Full Text] [Related]
3. The crystal structure of the PB2 cap-binding domain of influenza B virus reveals a novel cap recognition mechanism.
Liu Y; Yang Y; Fan J; He R; Luo M; Zheng X
J Biol Chem; 2015 Apr; 290(14):9141-9. PubMed ID: 25691568
[TBL] [Abstract][Full Text] [Related]
4. The structural basis for cap binding by influenza virus polymerase subunit PB2.
Guilligay D; Tarendeau F; Resa-Infante P; Coloma R; Crepin T; Sehr P; Lewis J; Ruigrok RW; Ortin J; Hart DJ; Cusack S
Nat Struct Mol Biol; 2008 May; 15(5):500-6. PubMed ID: 18454157
[TBL] [Abstract][Full Text] [Related]
5. Structural insight into cap-snatching and RNA synthesis by influenza polymerase.
Reich S; Guilligay D; Pflug A; Malet H; Berger I; Crépin T; Hart D; Lunardi T; Nanao M; Ruigrok RW; Cusack S
Nature; 2014 Dec; 516(7531):361-6. PubMed ID: 25409151
[TBL] [Abstract][Full Text] [Related]
6. Capped RNA primer binding to influenza polymerase and implications for the mechanism of cap-binding inhibitors.
Pflug A; Gaudon S; Resa-Infante P; Lethier M; Reich S; Schulze WM; Cusack S
Nucleic Acids Res; 2018 Jan; 46(2):956-971. PubMed ID: 29202182
[TBL] [Abstract][Full Text] [Related]
7. Structural and functional characterization of K339T substitution identified in the PB2 subunit cap-binding pocket of influenza A virus.
Liu Y; Qin K; Meng G; Zhang J; Zhou J; Zhao G; Luo M; Zheng X
J Biol Chem; 2013 Apr; 288(16):11013-23. PubMed ID: 23436652
[TBL] [Abstract][Full Text] [Related]
8. The cap-binding site of influenza virus protein PB2 as a drug target.
Severin C; Rocha de Moura T; Liu Y; Li K; Zheng X; Luo M
Acta Crystallogr D Struct Biol; 2016 Feb; 72(Pt 2):245-53. PubMed ID: 26894672
[TBL] [Abstract][Full Text] [Related]
9. The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit.
Dias A; Bouvier D; Crépin T; McCarthy AA; Hart DJ; Baudin F; Cusack S; Ruigrok RW
Nature; 2009 Apr; 458(7240):914-8. PubMed ID: 19194459
[TBL] [Abstract][Full Text] [Related]
10. Influenza Polymerase Can Adopt an Alternative Configuration Involving a Radical Repacking of PB2 Domains.
Thierry E; Guilligay D; Kosinski J; Bock T; Gaudon S; Round A; Pflug A; Hengrung N; El Omari K; Baudin F; Hart DJ; Beck M; Cusack S
Mol Cell; 2016 Jan; 61(1):125-37. PubMed ID: 26711008
[TBL] [Abstract][Full Text] [Related]
11. Bunyaviridae RNA polymerases (L-protein) have an N-terminal, influenza-like endonuclease domain, essential for viral cap-dependent transcription.
Reguera J; Weber F; Cusack S
PLoS Pathog; 2010 Sep; 6(9):e1001101. PubMed ID: 20862319
[TBL] [Abstract][Full Text] [Related]
12. Structure of a functional cap-binding domain in Rift Valley fever virus L protein.
Gogrefe N; Reindl S; Günther S; Rosenthal M
PLoS Pathog; 2019 May; 15(5):e1007829. PubMed ID: 31136637
[TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of influenza virus RNP interaction with RNA cap structures and comparison to human cap binding protein eIF4E.
Hooker L; Sully R; Handa B; Ono N; Koyano H; Klumpp K
Biochemistry; 2003 May; 42(20):6234-40. PubMed ID: 12755627
[TBL] [Abstract][Full Text] [Related]
14. A molecular modelling approach to understand the effect of co-evolutionary mutations (V344M, I354L) identified in the PB2 subunit of influenza A 2009 pandemic H1N1 virus on m7GTP ligand binding.
Bhoye D; Behera AK; Cherian SS
J Gen Virol; 2016 Aug; 97(8):1785-1796. PubMed ID: 27154164
[TBL] [Abstract][Full Text] [Related]
15. Structural and Thermodynamic Analysis of the Resistance Development to Pimodivir (VX-787), the Clinical Inhibitor of Cap Binding to PB2 Subunit of Influenza A Polymerase.
Gregor J; Radilová K; Brynda J; Fanfrlík J; Konvalinka J; Kožíšek M
Molecules; 2021 Feb; 26(4):. PubMed ID: 33673017
[TBL] [Abstract][Full Text] [Related]
16. A novel functional site in the PB2 subunit of influenza A virus essential for acetyl-CoA interaction, RNA polymerase activity, and viral replication.
Hatakeyama D; Shoji M; Yamayoshi S; Hirota T; Nagae M; Yanagisawa S; Nakano M; Ohmi N; Noda T; Kawaoka Y; Kuzuhara T
J Biol Chem; 2014 Sep; 289(36):24980-94. PubMed ID: 25063805
[TBL] [Abstract][Full Text] [Related]
17. Computational studies on the substrate interactions of influenza A virus PB2 subunit.
Wang YJ; Wang JF; Ping J; Yu Y; Wang Y; Lian P; Li X; Li YX; Hao P
PLoS One; 2012; 7(9):e44079. PubMed ID: 22957044
[TBL] [Abstract][Full Text] [Related]
18. Characterization of PA-N terminal domain of Influenza A polymerase reveals sequence specific RNA cleavage.
Datta K; Wolkerstorfer A; Szolar OH; Cusack S; Klumpp K
Nucleic Acids Res; 2013 Sep; 41(17):8289-99. PubMed ID: 23847103
[TBL] [Abstract][Full Text] [Related]
19. Recombinant-baculovirus-expressed PB2 subunit of the influenza A virus RNA polymerase binds cap groups as an isolated subunit.
Shi L; Galarza JM; Summers DF
Virus Res; 1996 Jun; 42(1-2):1-9. PubMed ID: 8806170
[TBL] [Abstract][Full Text] [Related]
20. Structural basis for therapeutic inhibition of influenza A polymerase PB2 subunit.
Ma X; Xie L; Wartchow C; Warne R; Xu Y; Rivkin A; Tully D; Shia S; Uehara K; Baldwin DM; Muiru G; Zhong W; Zaror I; Bussiere DE; Leonard VHJ
Sci Rep; 2017 Aug; 7(1):9385. PubMed ID: 28839261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
